CA1168403A - Methode d'extraction de propolis et poudre seche de propolis soluble dans l'eau - Google Patents

Methode d'extraction de propolis et poudre seche de propolis soluble dans l'eau

Info

Publication number: CA1168403A
Authority: CA; Canada
Prior art keywords: propolis; solvent; filtrate; alcohol; powder
Prior art date: 1982-10-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000413701A

Other languages

English (en)

Inventor

Zenon M. Sosnowski

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-10-19

Filing date

1982-10-19

Publication date

1984-06-05

1982-10-19 Application filed by Individual filed Critical Individual

1982-10-19 Priority to CA000413701A priority Critical patent/CA1168403A/fr

1984-06-05 Application granted granted Critical

1984-06-05 Publication of CA1168403A publication Critical patent/CA1168403A/fr

Status Expired legal-status Critical Current

Links

241000241413 Propolis Species 0.000 title claims abstract description 219
229940069949 propolis Drugs 0.000 title claims abstract description 218
238000000034 method Methods 0.000 title claims abstract description 108
239000000843 powder Substances 0.000 title claims abstract description 104
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 34
239000002994 raw material Substances 0.000 claims abstract description 14
239000002904 solvent Substances 0.000 claims description 81
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 73
239000000243 solution Substances 0.000 claims description 71
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 41
239000000706 filtrate Substances 0.000 claims description 41
235000019441 ethanol Nutrition 0.000 claims description 30
239000000203 mixture Substances 0.000 claims description 30
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 18
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 14
238000011534 incubation Methods 0.000 claims description 14
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 12
239000007864 aqueous solution Substances 0.000 claims description 12
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
238000001914 filtration Methods 0.000 claims description 10
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 10
238000004108 freeze drying Methods 0.000 claims description 9
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
238000000746 purification Methods 0.000 claims description 7
239000002202 Polyethylene glycol Substances 0.000 claims description 6
235000013871 bee wax Nutrition 0.000 claims description 6
239000012166 beeswax Substances 0.000 claims description 6
SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 6
BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 6
229920001223 polyethylene glycol Polymers 0.000 claims description 6
229960000583 acetic acid Drugs 0.000 claims description 5
239000012362 glacial acetic acid Substances 0.000 claims description 5
238000013019 agitation Methods 0.000 claims description 4
238000001816 cooling Methods 0.000 claims description 4
239000012467 final product Substances 0.000 claims description 4
230000000737 periodic effect Effects 0.000 claims description 4
229960002903 benzyl benzoate Drugs 0.000 claims description 3
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims 2
238000012795 verification Methods 0.000 claims 2
239000000284 extract Substances 0.000 abstract description 14
230000000844 anti-bacterial effect Effects 0.000 abstract description 7
230000001172 regenerating effect Effects 0.000 abstract description 6
230000003444 anaesthetic effect Effects 0.000 abstract description 4
230000000202 analgesic effect Effects 0.000 abstract description 3
239000006071 cream Substances 0.000 description 30
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
239000002674 ointment Substances 0.000 description 14
239000002537 cosmetic Substances 0.000 description 11
239000006210 lotion Substances 0.000 description 10
238000002360 preparation method Methods 0.000 description 9
239000000126 substance Substances 0.000 description 9
239000000470 constituent Substances 0.000 description 8
239000003925 fat Substances 0.000 description 8
239000003960 organic solvent Substances 0.000 description 8
239000000047 product Substances 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 7
239000004264 Petrolatum Substances 0.000 description 7
-1 Polyoxyethylene Polymers 0.000 description 7
238000009472 formulation Methods 0.000 description 7
229940066842 petrolatum Drugs 0.000 description 7
235000019271 petrolatum Nutrition 0.000 description 7
241001465754 Metazoa Species 0.000 description 6
BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
238000000605 extraction Methods 0.000 description 6
235000011187 glycerol Nutrition 0.000 description 6
239000002736 nonionic surfactant Substances 0.000 description 6
230000003716 rejuvenation Effects 0.000 description 6
239000000829 suppository Substances 0.000 description 6
239000004094 surface-active agent Substances 0.000 description 6
208000024891 symptom Diseases 0.000 description 6
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
208000009889 Herpes Simplex Diseases 0.000 description 5
229940092738 beeswax Drugs 0.000 description 5
239000007903 gelatin capsule Substances 0.000 description 5
239000011521 glass Substances 0.000 description 5
239000000463 material Substances 0.000 description 5
239000003755 preservative agent Substances 0.000 description 5
239000000600 sorbitol Substances 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
241000256844 Apis mellifera Species 0.000 description 4
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
241000700605 Viruses Species 0.000 description 4
239000012675 alcoholic extract Substances 0.000 description 4
230000003078 antioxidant effect Effects 0.000 description 4
239000002775 capsule Substances 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
239000012153 distilled water Substances 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
239000002480 mineral oil Substances 0.000 description 4
235000010446 mineral oil Nutrition 0.000 description 4
239000003921 oil Substances 0.000 description 4
229940060184 oil ingredients Drugs 0.000 description 4
235000019198 oils Nutrition 0.000 description 4
239000002453 shampoo Substances 0.000 description 4
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
241000251468 Actinopterygii Species 0.000 description 3
241000792859 Enema Species 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
239000004166 Lanolin Substances 0.000 description 3
239000001888 Peptone Substances 0.000 description 3
108010080698 Peptones Proteins 0.000 description 3
229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
230000001476 alcoholic effect Effects 0.000 description 3
229960005274 benzocaine Drugs 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
239000003814 drug Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000007920 enema Substances 0.000 description 3
230000001815 facial effect Effects 0.000 description 3
239000000796 flavoring agent Substances 0.000 description 3
235000013305 food Nutrition 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000002664 inhalation therapy Methods 0.000 description 3
229940039717 lanolin Drugs 0.000 description 3
231100000518 lethal Toxicity 0.000 description 3
230000001665 lethal effect Effects 0.000 description 3
230000004060 metabolic process Effects 0.000 description 3
239000006072 paste Substances 0.000 description 3
235000019319 peptone Nutrition 0.000 description 3
241001529453 unidentified herpesvirus Species 0.000 description 3
235000007173 Abies balsamea Nutrition 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 2
208000035484 Cellulite Diseases 0.000 description 2
241000709661 Enterovirus Species 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
208000004898 Herpes Labialis Diseases 0.000 description 2
206010020649 Hyperkeratosis Diseases 0.000 description 2
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
244000018716 Impatiens biflora Species 0.000 description 2
XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 2
206010067152 Oral herpes Diseases 0.000 description 2
229920001214 Polysorbate 60 Polymers 0.000 description 2
206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000003602 anti-herpes Effects 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000003125 aqueous solvent Substances 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
235000021302 avocado oil Nutrition 0.000 description 2
239000008163 avocado oil Substances 0.000 description 2
235000019445 benzyl alcohol Nutrition 0.000 description 2
230000017531 blood circulation Effects 0.000 description 2
239000004359 castor oil Substances 0.000 description 2
235000019438 castor oil Nutrition 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000002316 cosmetic surgery Methods 0.000 description 2
229940109239 creatinine Drugs 0.000 description 2
229940059082 douche Drugs 0.000 description 2
229940079593 drug Drugs 0.000 description 2
229940079360 enema for constipation Drugs 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
239000003292 glue Substances 0.000 description 2
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000000774 hypoallergenic effect Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
235000019388 lanolin Nutrition 0.000 description 2
239000007788 liquid Substances 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
230000000394 mitotic effect Effects 0.000 description 2
230000003020 moisturizing effect Effects 0.000 description 2
210000000282 nail Anatomy 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
239000011591 potassium Substances 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
238000011160 research Methods 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
208000008742 seborrheic dermatitis Diseases 0.000 description 2
239000012177 spermaceti Substances 0.000 description 2
229940084106 spermaceti Drugs 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
235000015112 vegetable and seed oil Nutrition 0.000 description 2
239000008158 vegetable oil Substances 0.000 description 2
239000003021 water soluble solvent Substances 0.000 description 2
210000002268 wool Anatomy 0.000 description 2
DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
108010051457 Acid Phosphatase Proteins 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
241001116389 Aloe Species 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
241000256837 Apidae Species 0.000 description 1
241000086254 Arnica montana Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
YTGPDOZPYUJVQM-UHFFFAOYSA-N C(=O)OCCC(C)C.C(CCC)(=O)OCCC(C)C.C(C1=CC=CC=C1)(=O)OCCC(C)C.C(C)OCCO Chemical compound C(=O)OCCC(C)C.C(CCC)(=O)OCCC(C)C.C(C1=CC=CC=C1)(=O)OCCC(C)C.C(C)OCCO YTGPDOZPYUJVQM-UHFFFAOYSA-N 0.000 description 1
SLHNTCJRBOZLFZ-UHFFFAOYSA-N C(CO)O.CS(=O)C.C(C(C)O)O Chemical compound C(CO)O.CS(=O)C.C(C(C)O)O SLHNTCJRBOZLFZ-UHFFFAOYSA-N 0.000 description 1
AJZKKBATFPWCGJ-UHFFFAOYSA-N CC(C)=O.O=C(OCc1ccccc1)c1ccccc1 Chemical compound CC(C)=O.O=C(OCc1ccccc1)c1ccccc1 AJZKKBATFPWCGJ-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
208000003643 Callosities Diseases 0.000 description 1
235000002566 Capsicum Nutrition 0.000 description 1
240000008574 Capsicum frutescens Species 0.000 description 1
206010008342 Cervix carcinoma Diseases 0.000 description 1
241000723346 Cinnamomum camphora Species 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
206010010741 Conjunctivitis Diseases 0.000 description 1
208000001840 Dandruff Diseases 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
206010012444 Dermatitis diaper Diseases 0.000 description 1
208000003105 Diaper Rash Diseases 0.000 description 1
208000000655 Distemper Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
206010018852 Haematoma Diseases 0.000 description 1
208000037319 Hepatitis infectious Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
241000257303 Hymenoptera Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
229940124091 Keratolytic Drugs 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
208000007101 Muscle Cramp Diseases 0.000 description 1
AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
201000009053 Neurodermatitis Diseases 0.000 description 1
244000061176 Nicotiana tabacum Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
206010049752 Peau d'orange Diseases 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
101800000789 Protease-polymerase p70 Proteins 0.000 description 1
101800000786 Protease-polymerase p76 Proteins 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
101150054830 S100A6 gene Proteins 0.000 description 1
241000242583 Scyphozoa Species 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
244000303379 Styrax officinalis Species 0.000 description 1
235000001361 Styrax officinalis Nutrition 0.000 description 1
102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
241000779819 Syncarpia glomulifera Species 0.000 description 1
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
244000269722 Thea sinensis Species 0.000 description 1
208000002474 Tinea Diseases 0.000 description 1
244000007731 Tolu balsam tree Species 0.000 description 1
235000007423 Tolu balsam tree Nutrition 0.000 description 1
241000159243 Toxicodendron radicans Species 0.000 description 1
241000893966 Trichophyton verrucosum Species 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
208000006374 Uterine Cervicitis Diseases 0.000 description 1
206010046914 Vaginal infection Diseases 0.000 description 1
201000008100 Vaginitis Diseases 0.000 description 1
229930003779 Vitamin B12 Natural products 0.000 description 1
208000000260 Warts Diseases 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
206010000496 acne Diseases 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
235000011399 aloe vera Nutrition 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
238000010171 animal model Methods 0.000 description 1
210000001557 animal structure Anatomy 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000001387 anti-histamine Effects 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
230000001153 anti-wrinkle effect Effects 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000006161 blood agar Substances 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229960000846 camphor Drugs 0.000 description 1
229930008380 camphor Natural products 0.000 description 1
239000001390 capsicum minimum Substances 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000036232 cellulite Effects 0.000 description 1
201000010881 cervical cancer Diseases 0.000 description 1
206010008323 cervicitis Diseases 0.000 description 1
235000019504 cigarettes Nutrition 0.000 description 1
239000010634 clove oil Substances 0.000 description 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
239000008294 cold cream Substances 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
239000008341 cosmetic lotion Substances 0.000 description 1
238000004042 decolorization Methods 0.000 description 1
208000002925 dental caries Diseases 0.000 description 1
210000004262 dental pulp cavity Anatomy 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
206010014599 encephalitis Diseases 0.000 description 1
229940095399 enema Drugs 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
210000004905 finger nail Anatomy 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
210000004051 gastric juice Anatomy 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229940074046 glyceryl laurate Drugs 0.000 description 1
235000019382 gum benzoic Nutrition 0.000 description 1
239000003722 gum benzoin Substances 0.000 description 1
208000005252 hepatitis A Diseases 0.000 description 1
235000012907 honey Nutrition 0.000 description 1
239000003906 humectant Substances 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
201000006747 infectious mononucleosis Diseases 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
229940041682 inhalant solution Drugs 0.000 description 1
208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
229960004592 isopropanol Drugs 0.000 description 1
230000001530 keratinolytic effect Effects 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
230000003902 lesion Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000000865 liniment Substances 0.000 description 1
235000021388 linseed oil Nutrition 0.000 description 1
239000000944 linseed oil Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
239000012528 membrane Substances 0.000 description 1
229960001047 methyl salicylate Drugs 0.000 description 1
238000009629 microbiological culture Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
239000001673 myroxylon balsanum l. absolute Substances 0.000 description 1
229940100657 nasal ointment Drugs 0.000 description 1
201000009240 nasopharyngitis Diseases 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
239000002304 perfume Substances 0.000 description 1
239000001739 pinus spp. Substances 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
230000000063 preceeding effect Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
208000020029 respiratory tract infectious disease Diseases 0.000 description 1
229940109850 royal jelly Drugs 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
210000004761 scalp Anatomy 0.000 description 1
210000004999 sex organ Anatomy 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
201000009890 sinusitis Diseases 0.000 description 1
201000010153 skin papilloma Diseases 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
239000000344 soap Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001587 sorbitan monostearate Substances 0.000 description 1
235000011076 sorbitan monostearate Nutrition 0.000 description 1
229940035048 sorbitan monostearate Drugs 0.000 description 1
239000011232 storage material Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
238000010257 thawing Methods 0.000 description 1
239000010409 thin film Substances 0.000 description 1
229940088660 tolu balsam Drugs 0.000 description 1
239000000606 toothpaste Substances 0.000 description 1
229940034610 toothpaste Drugs 0.000 description 1
229940036248 turpentine Drugs 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
230000003253 viricidal effect Effects 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
239000011715 vitamin B12 Substances 0.000 description 1
235000019163 vitamin B12 Nutrition 0.000 description 1
239000002699 waste material Substances 0.000 description 1
239000001993 wax Substances 0.000 description 1
230000037303 wrinkles Effects 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Landscapes

Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CA000413701A 1982-10-19 1982-10-19 Methode d'extraction de propolis et poudre seche de propolis soluble dans l'eau Expired CA1168403A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000413701A CA1168403A (fr)	1982-10-19	1982-10-19	Methode d'extraction de propolis et poudre seche de propolis soluble dans l'eau

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000413701A CA1168403A (fr)	1982-10-19	1982-10-19	Methode d'extraction de propolis et poudre seche de propolis soluble dans l'eau

Publications (1)

Publication Number	Publication Date
CA1168403A true CA1168403A (fr)	1984-06-05

Family

ID=4123788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000413701A Expired CA1168403A (fr)	1982-10-19	1982-10-19	Methode d'extraction de propolis et poudre seche de propolis soluble dans l'eau

Country Status (1)

Country	Link
CA (1)	CA1168403A (fr)

1982
- 1982-10-19 CA CA000413701A patent/CA1168403A/fr not_active Expired

Legal Events

Date	Code	Title	Description
2001-06-05	MKEX	Expiry

Publication	Publication Date	Title
US4382886A (en)	1983-05-10	Method for extracting propolis and water soluble dry propolis powder
EP0109993B1 (fr)	1989-02-08	Méthode d'extraction de la propolis, poudre sèche de propolis soluble dans l'eau ainsi obtenue et préparations cosmétiques et pharmaceutiques la contenant
JP3499616B2 (ja)	2004-02-23	ヒドロキシチロソール、メラニン生成抑制剤又は過酸化脂質生成抑制剤への応用
US5466455A (en)	1995-11-14	Polyphase fluid-extraction process, resulting products and methods of use
AU639721B2 (en)	1993-08-05	Aloe water, preparation process and compositions containing it
KR20110082292A (ko)	2011-07-19	아토피 및 여드름 피부에 효능을 보이는 황칠나무 추출물
JP2006137690A (ja)	2006-06-01	皮膚外用剤およびヒアルロン酸産生促進剤
EP1175908A1 (fr)	2002-01-30	Oleoresine d'hypericum perforatum l., procede d'obtention et utilisation
KR100530843B1 (ko)	2005-11-23	동충하초 추출물을 유효성분으로 포함하는 항염 조성물
CN113925907A (zh)	2022-01-14	一种抑菌抗炎、抗过敏的组合物及其制备方法和用途
HK1045813A1 (en)	2002-12-13	Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract
CA1168403A (fr)	1984-06-05	Methode d'extraction de propolis et poudre seche de propolis soluble dans l'eau
JP4197194B2 (ja)	2008-12-17	細胞間接着抑制用経口投与剤
JPH03163026A (ja)	1991-07-15	血管拡張剤
KR100310613B1 (ko)	2001-10-12	5알파-리덕테이즈의 활성을 억제하는 속수자 추출물, 및 이를 함유한 여드름 또는 피지억제 화장료 또는 피부도포의약품
JPS5913709A (ja)	1984-01-24	モイスチヤライザ−
KR101833025B1 (ko)	2018-04-13	희렴 추출물을 포함하는 여드름 개선용, 예방 및 치료용 조성물
CN102068482B (zh)	2014-01-29	紫景天总黄酮及其提取方法和药物用途
KR20220065394A (ko)	2022-05-20	한방복합추출물을 유효성분으로 함유하는 탈모방지 또는 두피개선용 화장료 조성물
NZ202633A (en)	1986-01-24	Method for extracting propolis from raw propolis and beeswax to provide a dry soluble propolis powder
CN110403891A (zh)	2019-11-05	一种具有口腔保健作用的中草药牙膏
RU2095052C1 (ru)	1997-11-10	Состав для профилактики заболеваний пародонта
NO824086L (no)	1984-06-07	Fremgangsmaate for fremstilling av propolis
JPS5996199A (ja)	1984-06-02	蜂ろうの抽出法並びに水可溶性乾燥蜂ろう粉末
CN114432222B (zh)	2023-07-21	一种用于口腔护理的水剂及其制备方法